The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Nitasha Sarswat and Jeremy Slivnick.
Connection Strength

2.919
  1. Incremental prognostic value of cardiac magnetic resonance beyond biomarker staging in transthyretin cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2026 Sep 01; 27(9):1603-1612.
    View in: PubMed
    Score: 0.248
  2. AL Cardiac Amyloidosis Mimicking Dilated Cardiomyopathy With Reduced Ejection Fraction and Absent Apical Sparing. JACC Case Rep. 2026 Aug 26; 109997.
    View in: PubMed
    Score: 0.247
  3. Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection. Circ Cardiovasc Imaging. 2026 Jun; 19(6):e019610.
    View in: PubMed
    Score: 0.243
  4. Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Eur Heart J. 2025 10 22; 46(40):4090-4101.
    View in: PubMed
    Score: 0.233
  5. Age-Adjusted Echocardiographic Parameters for Differentiating Cardiac Amyloidosis and Hypertrophic Cardiomyopathy. J Am Soc Echocardiogr. 2025 Dec; 38(12):1236-1238.
    View in: PubMed
    Score: 0.231
  6. Cardiac Magnetic Resonance-based Tissue Characterization for Detection of Transthyretin Cardiac Amyloidosis with Negative or Equivocal Technetium-Pyrophosphate Scan. JACC Cardiovasc Imaging. 2025 Nov; 18(11):1272-1275.
    View in: PubMed
    Score: 0.229
  7. Disparities in diagnosis and outcomes in American patients with transthyretin cardiac amyloidosis. Int J Cardiovasc Imaging. 2025 Aug; 41(8):1487-1496.
    View in: PubMed
    Score: 0.227
  8. Perivascular Amyloid Deposition in Immunoglobulin Light Chain Cardiac Amyloidosis and Its Implications on Echocardiographic Cardiac Remodeling. J Am Soc Echocardiogr. 2024 10; 37(10):1010-1012.
    View in: PubMed
    Score: 0.213
  9. Preservation of Circumferential and Radial Left Ventricular Function as a Mitigating Mechanism for Impaired Longitudinal Strain in Early Cardiac Amyloidosis. J Am Soc Echocardiogr. 2023 12; 36(12):1290-1301.
    View in: PubMed
    Score: 0.202
  10. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains. Eur Heart J Cardiovasc Imaging. 2023 05 31; 24(6):829-837.
    View in: PubMed
    Score: 0.198
  11. Vascular Amyloid Deposition Is Highly Prevalent in Immunoglobulin Light Chain Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2023 08; 16(8):1121-1123.
    View in: PubMed
    Score: 0.196
  12. Serum amyloidosis: a cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2023 03 21; 24(4):e59.
    View in: PubMed
    Score: 0.195
  13. Clinical and Echocardiographic Features of Individuals With Cardiac Amyloidosis at Risk for Future Thrombus Formation. J Am Soc Echocardiogr. 2025 Feb; 38(2):135-137.
    View in: PubMed
    Score: 0.055
  14. Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
    View in: PubMed
    Score: 0.053
  15. ATTR Gene Variants in HCM. JACC Case Rep. 2024 Mar 20; 29(6):102236.
    View in: PubMed
    Score: 0.052
  16. Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival. Curr Probl Cardiol. 2024 Apr; 49(4):102417.
    View in: PubMed
    Score: 0.052
  17. Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2022 08; 35(8):829-835.e1.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.